PepsiCo Boosts Forecast as Sales Withstand Ozempic Threat

PepsiCo Inc. says appetite-suppressing drugs haven’t affected sales of its snacks and sodas, though the company is focused on package size as it aims to reach its raised annual forecast.

Author